Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

MGMT-NET: O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents (MGMT-NET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03217097
Recruitment Status : Recruiting
First Posted : July 13, 2017
Last Update Posted : January 22, 2020
Information provided by (Responsible Party):
Hospices Civils de Lyon

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : November 2021